Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3129-2026

StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system. Recall

StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.

FDA recall Class I

Ongoing

FDA lists this Class I recall for StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3129-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jul 29, 2026
FDA report date
Sep 23, 2026
Quantity in commerce
10,941 units
Distribution
See key details
FDA cause
Software design

What is being recalled?

StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.

Affected model & UDI checker

Search the exact identifiers published for Z-3129-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
66739StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.Check source noticeNot specified
Not specifiedStatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.Check source notice0038548063685
FDA code information

Model No: 66739. UDI-DI: 0038548063685. Software Versions: All versions 0.00.13.10 through 1.5.14.25.

View the original FDA recall notice

Why was this product recalled?

A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the prior barcode information remaining displayed on the screen for the current test. When this defect occurs and the operator accepts the incorrectly displayed patient information without recognizing the mismatch, the current patient's glucose result will be incorrectly assigned to the previous patient's medical record and transmitted to the data management system (DMS), and the current patient's medical record will not receive a result, leaving their glucose status unrecorded and their clinical management without the information needed to guide treatment decisions. The previous patient, whose medical record now contains a glucose result that does not belong to them, may receive inappropriate clinical intervention based on that erroneous result, particularly in critically ill patients, neonates, and infants who cannot communicate symptoms or self-treat. The defect also affects QC barcode scanning: if a QC scan triggers the same retention behavior, QC results may be attributed to an incorrect identifier or QC tests may fail without the user recognizing the underlying cause. This defect does not affect the analytical accuracy of glucose measurements.

What actions did Nova Biomedical Corporation take?

Nova Biomedical issued an "URGENT MEDICAL DEVICE RECALL" Customer Advisor Notice to its consignees on 7/29/2026 via email. The notice explained the issue, potential risk, and requested consignees follow the below specific recommendations until a permanent resolution can be provided. 1. Verifying patient information displayed on the meter exactly matches the scanned patient identification after every patient barcode scan and before accepting the patient's record or result. 2. If the displayed patient information does not match the scanned patient identification, discontinue testing with the meter and notify your administrator. 3. Nova recommends that a copy of this notice is provided to all end users within your facilities that use the StatStrip (Gen 2) Glucose Hospital Meter Systems for patient testing and care. Additionally, Nova recommends placing a copy of this notice in all areas where the meters are stored and used. 4. Complete and return the acknowledgement form to appropriate emails: North America- [email protected]; European Union- [email protected] and all other international [email protected]. Nova is actively working on a planned firmware update to address this issue. As a precautionary measure, Nova has implemented a shipment hold on all StatStrip (Gen 2) Glucose Hospital Meter Systems while corrective actions are being developed and validated. Efforts are underway for the development and validation of the firmware update to address this issue. Nova will communicate availability as soon as validation activities are completed targeting September 2026. If you have questions regarding this notice, please contact Nova Biomedical Technical Support at 1 (800) 545-6682 (USA) or at (800) 263-5999 (Canada). Nova Biomedical Technical Support can be reached 24 hours a day, 7 days a week, 365 days a year. For customers outside of the USA or Canada, please contact your authorized Nova Biomedical distributor.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology